Enhanced system to manage screening for colorectal cancer, the second leading cause of cancer death in Canada, being deployed in Newfoundland and Labrador
TORONTO, July 23, 2012 /CNW/ - NexJ Systems Inc., (TSX: NXJ) a leading provider of next generation enterprise customer relationship management (CRM) solutions, today announced that Eastern Health, the largest, integrated health authority in Newfoundland and Labrador, has begun use of the NexJ Disease Screening solution for its Colorectal Screening Information and Reporting System project. This makes Eastern Health the second Canadian healthcare provider to use NexJ Disease Screening for colorectal screening for large populations of patients.
According to the Canadian Cancer Society, colorectal cancer is the second-leading cause of cancer death in Canada. In 2012 an estimated 23,300 Canadians (13,000 men - 10,300 women) will be diagnosed with colorectal cancer and 9,200 (5,000 men - 4,200 women) will die from it. On average, 64 Canadians will be diagnosed with colorectal cancer every day and 25 will die from the disease every day. 1
"NexJ Disease Screening is proven to improve wellness within a population as evidenced in Saskatchewan by the Saskatchewan Cancer Agency. Eastern Health now joins Saskatchewan in use of our solution for their population-based disease surveillance programs which have successfully identified pre-symptomatic individuals with colorectal cancer," said Eric Gombrich, SVP & GM, Health Solutions Group, NexJ Systems. "A significant contributing factor in Saskatchewan's early detection success has been the high participation rate of nearly 50 per cent of the population identified by the Screening Program for Colorectal Cancer. This approach has proven to enable dramatically higher participation than in other initiatives."NexJ Disease Screening enables proactive, targeted screening for diseases across a population. Health provider networks use the solution to identify treatable diseases early, enable coordinated action when disease is detected, and analyze results to improve screening programs and public health.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts